Matthew Dankner

16PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 26, 2025
Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis.

Matthew Dankner, Laurie-Rose Dubé, Mark Sorin

|Jan 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers.

Matthew Dankner, Emmanuelle Rousselle, Sarah Petrecca

|Dec 16, 2024
Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scans.

Keyhan Najafian, Benjamin Rehany, Alexander Nowakowski

|Oct 25, 2024
Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System Metastases.

David J H Bian, Sara F Cohen, Anna-Maria Lazaratos

|Jan 26, 2024
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers.

Suzanne Kazandjian, Emmanuelle Rousselle, Matthew Dankner

Pageof 3